4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Citius Pharmaceuticals, Inc. (CTXR) operates in the Biotechnology industry and is headquartered in Cranford, United States with about 23 employees. Its market capitalization is roughly $15 million. In the fiscal year ended 2025-09-30, CTXR reported $0M in revenue and ($37M) in net income.
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma.
Interactive charts & full statements → Open the CTXR valuation workbench →
| Income statement | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($38M) | ($42M) | ($37M) | ($33M) | — |
| Net Income | ($37M) | ($39M) | ($32M) | ($34M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $2M | $4M | $0M | $0M | $0M | — |
| Gross Profit | $1M | $3M | — | — | $0M | $0M |
| Operating Income (EBIT) | ($32M) | ($9M) | ($8M) | ($9M) | ($11M) | — |
| Net Income | ($21M) | ($8M) | ($8M) | ($9M) | ($11M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Total Assets | $131M | $117M | $104M | $114M | — |
| Total Liabilities | $53M | $42M | $12M | $11M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CTXR viewer.
About TickerBase · Data methodology & sources